Tyrosine kinase inhibitors and interferon‐α increase tunneling nanotube (TNT) formation and cell adhesion in chronic myeloid leukemia (CML) cell lines-Reference-Cited by-同舟云学术

Tyrosine kinase inhibitors and interferon‐α increase tunneling nanotube (TNT) formation and cell adhesion in chronic myeloid leukemia (CML) cell lines

Published:2020-01-16 Issue:3 Volume:34 Page:3773-3791
ISSN:0892-6638
Container-title:The FASEB Journal
language:en
Short-container-title:FASEB j.

Author:

Omsland Maria¹²,Andresen Vibeke¹³,Gullaksen Stein‐Erik¹³,Ayuda‐Durán Pilar⁴,Popa Mihaela³⁵,Hovland Randi⁶,Brendehaug Atle⁶,Enserink Jorrit⁴,McCormack Emmet¹,Gjertsen Bjørn Tore¹³

Affiliation:

1. Centre for Cancer Biomarkers CCBIO Department of Clinical Science University of Bergen Bergen Norway

2. Animal Models and Retroviral Vaccines Section Vaccine Branch National Cancer InstituteNational Institutes of Health Bethesda MD USA

3. Department of Internal Medicine, Hematology Section Haukeland University Hospital Bergen Norway

4. Department of Molecular Cell Biology Institute for Cancer Research The Norwegian Radium HospitalOslo University Hospital Oslo Norway

5. KinN Therapeutics Bergen Norway

6. Department of Medical Genetics Haukeland University Hospital Bergen Norway

Funder

Universitetet i Bergen

National Institutes of Health

National Cancer Institute

Helse Vest

Kreftforeningen

Norges Forskningsråd

Publisher

Wiley

Subject

Genetics,Molecular Biology,Biochemistry,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1096/fj.201802061RR

Reference97 articles.

1. Interferon alfa versus chemotherapy for chronic myeloid leukemia: a meta‐analysis of seven randomized trials: Chronic Myeloid Leukemia Trialists' collaborative group;CML Trialists' Collaborative Group, C. T. S. U., Radcliffe Infirmary, Oxford;J Natl Cancer Inst,1997

2. Hematopoietic stem cell transplantation for hematological malignancies in Europe

3. Hematologic Remission and Cytogenetic Improvement Induced by Recombinant Human Interferon AlphaAin Chronic Myelogenous Leukemia

4. Clinical investigation of human alpha interferon in chronic myelogenous leukemia

5. Combination of pegylated IFN-α2b with imatinib increases molecular response rates in patients with low- or intermediate-risk chronic myeloid leukemia

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tunneling nanotubes: The intercellular conduits contributing to cancer pathogenesis and its therapy;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2023-11

2. Leishmania donovani Exploits Tunneling Nanotubes for Dissemination and Propagation of B Cell Activation;Microbiology Spectrum;2023-08-17

3. Transient Viral Activation in Human T Cell Leukemia Virus Type 1-Infected Macaques Treated With Pomalidomide;Frontiers in Medicine;2022-05-05

4. Fluorescent Artificial Antigens Revealed Extended Membrane Networks Utilized by Live Dendritic Cells for Antigen Uptake;Nano Letters;2022-05-02

5. NK cells and monocytes modulate primary HTLV-1 infection;PLOS Pathogens;2022-04-04